Rapamycin relieves lentiviral vector transduction resistance in human and mouse hematopoietic stem cells

Transplantation of genetically modified hematopoietic stem cells (HSCs) is a promising therapeutic strategy for genetic diseases, HIV, and cancer. However, a barrier for clinical HSC gene therapy is the limited efficiency of gene delivery via lentiviral vectors (LVs) into HSCs. We show here that rap...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Wang, Cathy X., Sather, Blythe D., Wang, Xuefeng, Adair, Jennifer, Khan, Iram, Singh, Swati, Lang, Shanshan, Adams, Amie, Curinga, Gabrielle, Kiem, Hans-Peter, Miao, Carol H., Rawlings, David J., Torbett, Bruce E.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2014
Assuntos:
Gene Therapy
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4126331/
https://ncbi.nlm.nih.gov/pubmed/24914132
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2013-12-546218
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados